Add like
Add dislike
Add to saved papers

Implementation of a pre-operative decolonization protocol of Methicillin Resistance Staphylococcus aureus in elective orthopedic surgery at Manatí Medical Center: Pilot Study.

Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of S. aureus that shows resistance to multiple antibiotics. Up to 30% of S. aureus strains isolated from nosocomial infections are MRSA, and it has become a growing problem for public health. The cost of MRSA infection is also having a huge impact financially and results in considerable resource utilization. Puerto Rico’s Legislature passed Law # 298 on October 19, 2012 for the control and prevention of MRSA infections in medical installations in Puerto Rico. In order to comply with the law we conducted a pilot study to identify possible setbacks of the implementation of the MRSA decolonization protocol as standard of care therapy in our institution while contributing to the process of quality improvement and patient safety. Nasal swabs were taken at the Pre-admission Department and processed through a PCR-based MRSA detection assay. A protocol of decolonization in patients with positive results was implemented. The study showed that patients without apparent risk factors could be colonized either with MRSA or Methicillin-sensitive S. aureus (MSSA). The time between pre- admission and surgery was less than the indicated for a proper decolonization procedure. Therefore, 50% of the scheduled surgeries could have been postponed in case of positive MRSA or MSSA. In our experience patient’s education was crucial to guarantee compliance and adherence to treatment. In order to decrease risk of wound infection we recommend that both, screening process and decolonization if required, be performed before the preadmission appointment for elective surgery. This study provided a framework for MRSA pre-admission screening and decolonization in our Institution.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app